EARLY PHASE CLINICAL TRIAL UNITS (EPCTU): PHASE I CLINICAL TRIAL TO EVALUATE A SARS-COV-2 THERAPEUTIC

早期临床试验单位 (EPCTU)：评估 SARS-COV-2 治疗药物的 I 期临床试验

• 批准号: 10912967
• 负责人: CASEY LONG
• 金额: $ 180.08万
• 依托单位: DYNPORT VACCINE COMPANY, LLC
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-15 至 2024-03-01
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10912967
• 关键词: COVID-19 therapeutics; Clinical Trials Unit; Communicable Diseases; Intervention; Investigation; New Agents; Phase I Clinical Trials; Prevention; clinical trial implementation; coronavirus disease; early phase clinical trial

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases, and can carry out all aspects of interventional clinical trial implementation.

早期临床试验单位为研究治疗和预防传染病的新药物提供了一个工具，并可以进行干预性临床试验实施的所有方面。